EXAMINE THIS REPORT ON SODIUM PENTOBARBITAL SDS

pentobarbital will reduce the level or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with solid CYP3A4 inducers is not advisedpentobarbital will minimize the level or effect of atogepant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently